Product Name: Orforglipron Intermediate
Synonyms: 2H-Imidazol-2-one, 1-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-4,5,6,7-tetrahydro-4-methyl-2H-pyrazolo[4,3-c]pyridin-3-yl]-3-(4-fluoro-1-methyl-1H-indazol-5-yl)-1,3-dihydro-
CAS: 2212022-56-3

This is a key pharmaceutical intermediate used in the synthesis of Orforglipron and related drug candidates for the treatment of type 2 diabetes and other metabolic disorders.

Product Details:
- High purity pharmaceutical intermediate
- Used in GLP-1 receptor agonist synthesis
- Suitable for pharmaceutical research and development
- Meets strict quality standards for API synthesis

Applications:
- Pharmaceutical intermediate for drug synthesis
- Research and development of GLP-1 receptor agonists
- Type 2 diabetes drug development
- Metabolic disorder treatments

Quality: High purity product manufactured under strict quality control standards suitable for pharmaceutical applications.

Packaging: Available in various package sizes to meet customer requirements.

Storage: Store in a cool, dry place away from light and heat sources. Keep container tightly closed when not in use.